LACK OF REACTIVATION OF TUBERCULOSIS IN 12,319 PATIENTS WITH PSORIASIS, PSORIATIC ARTHRITIS AND ANKYLOSING SPONDYLITIS TREATED wail SECUKINUMAB: AN AD HOC ANALYSIS OF POOLED SAFETY DATA FROM 28 CLINICAL TRIALS

被引：0
|
作者：
Soriano, Enrique R. [1 ]
Elewski, Boni [2 ]
Baddley, John [2 ]
Deodhar, Atul [3 ]
Magrey, Marina [4 ]
Rich, Phoebe [5 ]
Soung, Jennifer [6 ]
Sharma, Abhishek [7 ]
Bao, Weibin [8 ]
Patekar, Manmath [9 ]
Lebwohl, Mark [10 ]
机构：
[1] Hosp Italiano Buenos Aires, Serv Clin Med, Seec Reumatol, Buenos Aires, DF, Argentina
[2] Univ Alabama Birmingham, Birmingham, AL USA
[3] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[4] Case Western Reserve Univ, Sch Med, MetroHlth Med Ctr, Cleveland, OH 44106 USA
[5] Oregon Dermatol & Res, Portland, OR USA
[6] Southern Calif Dermatol, Santa Ana, SC USA
[7] Novartis Healthcare Pvt Ltd, Hyderabad, India
[8] Novartis Pharmaceut, E Hanover, NJ USA
[9] Novartis Pharma AG, Basel, Switzerland
[10] Icahn Sch Med Mt Sinai, Kimberly & Eric J Waldman Dept Dermatol, New York, NY 10029 USA
来源：
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY | 2020年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
77
引用
收藏
页码：65 / 66
页数：2
相关论文
共 31 条
  • [21] Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn's disease
    Burmester, Gerd R.
    Panaccione, Remo
    Gordon, Kenneth B.
    McIlraith, Melissa J.
    Lacerda, Ana P. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 (04) : 517 - 524
  • [22] Secukinumab effects on cardiovascular risk factors in patients with psoriasis, psoriatic arthritis and axial spondyloarthritis: Results from post hoc analyses of pooled data from 19 phase 3/4 clinical studies
    Merola, Joseph F.
    McInnes, Iain B.
    Deodhar, Atul A.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB107 - AB107
  • [23] Rapid Onset of Efficacy in Patients with Active Psoriatic Arthritis Treated with Ixekizumab: A Pooled Analysis of Data from Two Phase III Clinical Trials
    Deodhar, Atul A.
    Papp, Kim A.
    Shuler, Catherine
    Park, So Young
    Kvien, Tore K.
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [24] RAPID ONSET OF EFFICACY IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS TREATED WITH IXEKIZUMAB: A POOLED ANALYSIS OF DATA FROM TWO PHASE III CLINICAL TRIALS
    Deodhar, A.
    Papp, K.
    Shuler, C. L.
    Park, S. Y.
    Kvien, T.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (04) : 755 - 755
  • [25] LONG-TERM GOLIMUMAB PERSISTENCE: 5-YEAR TREATMENT RETENTION DATA POOLED FROM FIVE PHASE III CLINICAL TRIALS IN PATIENTS WITH RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS, AND ANKYLOSING SPONDYLITIS
    Weinstein, C.
    Govoni, M.
    Lin, J.
    Meehan, A.
    Qureshi, Z.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 777 - 778
  • [26] Long-term golimumab persistence: Five-year treatment retention data pooled from pivotal Phase III clinical trials in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis
    Cindy L. J. Weinstein
    Alan G. Meehan
    Jianxin Lin
    Steven D. Briscoe
    Marinella Govoni
    Clinical Rheumatology, 2023, 42 : 3397 - 3405
  • [27] Long-term golimumab persistence: Five-year treatment retention data pooled from pivotal Phase III clinical trials in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis
    Weinstein, Cindy L. J.
    Meehan, Alan G.
    Lin, Jianxin
    Briscoe, Steven D.
    Govoni, Marinella
    CLINICAL RHEUMATOLOGY, 2023, 42 (12) : 3397 - 3405
  • [28] Secukinumab Effects on Cardiometabolic Risk and Systemic Inflammation in Patients with Psoriasis, Psoriatic Arthritis and Axial Spondyloarthritis: Results from Post Hoc Analyses of Pooled Data from 19 Phase 3/4 Clinical Studies
    Merola, Joseph
    McInnes, Iain
    Deodhar, Atul
    Quebe-Fehling, Erhard
    Aassi, Maher
    Peine, Michael
    Mehta, Nehal
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3837 - 3839
  • [29] Long-term safety of Ixekizumab in adults with psoriasis, psoriatic arthritis, or axial spondyloarthritis: a post-hoc analysis of final safety data from 25 randomized clinical trials
    Deodhar, Atul
    Blauvelt, Andrew
    Lebwohl, Mark
    Feely, Meghan
    Kronbergs, Andris
    Eberhart, Nadezhda
    Zhu, Danting
    Inman, Elsa
    Grace, Elsie
    Holzkaemper, Thorsten
    Rahman, Proton
    Marzo-Ortega, Helena
    Papp, Kim A.
    Merola, Joseph F.
    Gottlieb, Alice B.
    Schwartzman, Sergio
    ARTHRITIS RESEARCH & THERAPY, 2024, 26 (01)
  • [30] Long-term safety of Ixekizumab in adults with psoriasis, psoriatic arthritis, or axial spondyloarthritis: a post-hoc analysis of final safety data from 25 randomized clinical trials
    Atul Deodhar
    Andrew Blauvelt
    Mark Lebwohl
    Meghan Feely
    Andris Kronbergs
    Nadezhda Eberhart
    Danting Zhu
    Elsa Inman
    Elsie Grace
    Thorsten Holzkaemper
    Proton Rahman
    Helena Marzo-Ortega
    Kim A. Papp
    Joseph F. Merola
    Alice B. Gottlieb
    Sergio Schwartzman
    Arthritis Research & Therapy, 26
1234